Innovative AI-based technology for early detection and localization of anomalies in the cardiovascular system
Reference number | |
Coordinator | Beat Vascular Health AB |
Funding from Vinnova | SEK 300 000 |
Project duration | October 2023 - October 2024 |
Status | Completed |
Venture | Innovative Startups |
Call | Innovative Impact Startups autumn 2023 |
Important results from the project
We fulfilled our objective in the project. The market research confirmed that our technology would contribute value in many areas of the healthcare system, but also pointed to alternative applications that we will analyze further. The health economic evaluation exceeded our expectations and showed that our technology is very cost-effective as a screening method for certain patient groups with an increased risk of cardiovascular disease. It also provided a tool we can use for future analyses.
Expected long term effects
The results from the project are expected to contribute to the widespread integration of our technology into the healthcare system, enabling early detection and prevention. The market analysis gave us a better understanding of perspectives of users, customers and other stakeholders and helps us develop a user-centric product. The health economic evaluation provides concrete evidence for the value of our technology and will contribute to a faster implementation of our technology in healthcare.
Approach and implementation
We hired consulting expertise to perform each part, market research and health economic evaluation, in collaboration with us. Together with these experts, we set the structure for each part, with a focus on each part generating a concrete results, eg cost per QALY. During the course of the project, we have had regular reconciliations with each actor to be able to handle any questions and problems that arose during the work. The collaboration worked very well overall.